More about Torrent Pharmaceuticals Limited
Fundamentals for Torrent Pharmaceuticals Limited
Regulatory Filings for Torrent Pharmaceuticals Limited
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
Technicals for Torrent Pharmaceuticals Limited
Price Summary
Torrent Pharmaceuticals Limited's stock opened at 4231.7 on 2026-04-30, surged to 4234.7, hit a low of 4146.1, and closed up -1.1% at 4185.1, with 278058 shares traded.Over the past 52 weeks, the stock reached a maximum price of 4446.0 and a minimum price of 3127.8.
According to 28 analysts, the price of TORNTPHARM in the future is projected to be between 3876.0 and 5100.0, with an average expected price of 4540.3213.
Technicals
Support and Resistance: The current price is 4185.1, with support at 4092.2 and resistance at 4261.5. This range suggests that the price might move between these levels, with 4092.2 offering support and 4261.5 capping further gains for Torrent Pharmaceuticals Limited.Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for TORNTPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
Parabolic SAR: The PSAR continues to signal a bullish outlook, establishing a key support level that reinforces the market's upward momentum. This support could serve as a base for continued gains, suggesting that the bullish trend is likely to persist.
Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral for TORNTPHARM, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook